1A sadullah K,Sabat R,Wiese A,et al.Interleukin-10 in cutaneous disorders:implications for its pathophysiological importance and therapentic use.Arch Dermatol Res 1999;291(12):628-636.
2Farkas A,Kemeny L,Szony BJ,et al.Dithranall upregulates IL-10 receptors on the cultured human keratinocyte cell line Ha CaT.Inflam Res 2001;50(1):44-49.
3Asadullah K,Sterry W,Stephanek K,et al.Il-10 is a key cytokine in psoriasis.Proof of principle by IL-10 therapy:a new the rapeutic the approach.J Clin Invest 1998;101(4):783-794.
4Seifert M,Seerry W,Effenberger E,et al.The antipsoriatic activity of IL-10 is rather caused by effects on peripheral blood cells than by a direct effect on human keratinocytes.Arch Dermatol Res 2000;292(4):164-172.
5Dinarello CA.IL-18:A Th1-inducing,proinflammatory cytokine and new member of the IL-1 family.J Allergy Clin Immunol 1999;103(1Pt1):11-24.
6Mee JB,Alam Y,Groves RW.Human keratinocytes constitutively produce but do not process interleukin-18.Br J Dermatol 2000; 143(2):330-336.
7Oh tal Y,Hamada Y,Katsuoka K.Eepression of IL-18 in psoriasis.Arch Dermatol Res 2001;293(7):334-342.
8Blumberg H,Conklin D,Xu WF,et al.Interleukin 20:discovery receptor identification,and role in epidermal function.Cell 2001; 104(1):9-19.
9Rich BE,Kupper TS.Cytokines:IL-20-a new effectorin skin inflammation.Curr Biol 2001; 11(13):R531-R534.
10Sano S,Itami S,Takeda K,et al.Keratinocyte-specific ablation of stat 3 exhibits impaired skin remodeling.but does not affect skin morphogenesis.EMBO J 1999; 18(17):4657-4668.
二级参考文献1
1Natalia V. Konstantinova,Noreen A. Lemak,Madeleine Duvic. Nerve growth factor in normal and psoriatic skin equivalent models[J] 1998,Archives of Dermatological Research(11):610～614
7Viatour P,Merville MP,Bours V,et al.Phosphorylation of NF-kappa B and I kappa B protein:implications in cancer and inflammation[J].Trends Biochem Sci,2005,30(1):43.
8Ropars V,Despouy G,Stern MH,et al.The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB[J].PLoS One,2009,4(8):e6567.
9Idris AI,Libouban H,Nyangoga H,et al.Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo[J].Mol Cancer Ther,2009,8(8):2339.
10Aquila S,Weng ZY,Zeng YQ,et al.Inhibition of NF-kappaB activation and iNOS induction by ent-kaurane diterpenoids in LPS-stimulated RAW264.7 murine macrophages[J].J Nat Prod,2009,72(7):1269.
